Terri Booker’s body burns with pain. She’s one of the 100,000 Americans living with sickle cell disease – a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face. 

This episode of Targeting the Toughest Diseases is sponsored by Vertex Pharmaceuticals.

Terri Booker&rsquo;s body burns with pain. She&rsquo;s one of the 100,000 Americans living with sickle cell disease &ndash; a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face.&nbsp;
This episode of Targeting the Toughest Diseases is sponsored by Vertex Pharmaceuticals.

Barry Ritholtz speaks with the people that shape markets, investing and business.

Barry Ritholtz speaks with the people that shape markets, investing and business.

Bloomberg's Barry Ritholtz looks at the people and ideas that shape markets, investing and business.

Masters in Business

Targeting Sickle Cell Disease (Sponsored Content)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cefc9eca-c266-4351-89ea-b2de011b5fd8/transcript

Advertisement